Cargando…

Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy

PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ce, Zhang, Ji, Yu, Bing, Zheng, Haoze, Wu, Yibo, Lin, Zhixi, Ning, Boda, Yi, Jinling, Xie, Congying, Jin, Xiance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334519/
https://www.ncbi.nlm.nih.gov/pubmed/37434171
http://dx.doi.org/10.1186/s13014-023-02311-7
_version_ 1785070872904597504
author Han, Ce
Zhang, Ji
Yu, Bing
Zheng, Haoze
Wu, Yibo
Lin, Zhixi
Ning, Boda
Yi, Jinling
Xie, Congying
Jin, Xiance
author_facet Han, Ce
Zhang, Ji
Yu, Bing
Zheng, Haoze
Wu, Yibo
Lin, Zhixi
Ning, Boda
Yi, Jinling
Xie, Congying
Jin, Xiance
author_sort Han, Ce
collection PubMed
description PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measured PSQA results were retrospectively enrolled and divided into training and testing sets randomly at 7:3. PC metrics were calculated using house-built algorithm based on Matlab. Dosiomics features were extracted and selected using Random Forest (RF) from planning target volume (PTV) and overlap regions with 3D dose distributions. The top 50 dosiomics and 5 PC features were selected based on feature importance screening. A DL DenseNet was adapted and trained for the PSQA prediction. RESULTS: The measured average gamma passing rate (GPR) of these VMAT plans was 97.94% ± 1.87%, 94.33% ± 3.22%, and 87.27% ± 4.81% at the criteria of 3%/3 mm, 3%/2 mm, and 2%/2 mm, respectively. Models with PC features alone demonstrated the lowest area under curve (AUC). The AUC and sensitivity of PC and dosiomics (D) combined model at 2%/2 mm were 0.915 and 0.833, respectively. The AUCs of DL models were improved from 0.943, 0.849, 0.841 to 0.948, 0.890, 0.942 in the combined models (PC + D + DL) at 3%/3 mm, 3%/2 mm and 2%/2 mm, respectively. A best AUC of 0.942 with a sensitivity, specificity and accuracy of 100%, 81.8%, and 83.6% was achieved with combined model (PC + D + DL) at 2%/2 mm. CONCLUSIONS: Integrating DL with dosiomics and PC metrics is promising in the prediction of GPRs in PSQA for patients underwent VMAT.
format Online
Article
Text
id pubmed-10334519
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103345192023-07-12 Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy Han, Ce Zhang, Ji Yu, Bing Zheng, Haoze Wu, Yibo Lin, Zhixi Ning, Boda Yi, Jinling Xie, Congying Jin, Xiance Radiat Oncol Research PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measured PSQA results were retrospectively enrolled and divided into training and testing sets randomly at 7:3. PC metrics were calculated using house-built algorithm based on Matlab. Dosiomics features were extracted and selected using Random Forest (RF) from planning target volume (PTV) and overlap regions with 3D dose distributions. The top 50 dosiomics and 5 PC features were selected based on feature importance screening. A DL DenseNet was adapted and trained for the PSQA prediction. RESULTS: The measured average gamma passing rate (GPR) of these VMAT plans was 97.94% ± 1.87%, 94.33% ± 3.22%, and 87.27% ± 4.81% at the criteria of 3%/3 mm, 3%/2 mm, and 2%/2 mm, respectively. Models with PC features alone demonstrated the lowest area under curve (AUC). The AUC and sensitivity of PC and dosiomics (D) combined model at 2%/2 mm were 0.915 and 0.833, respectively. The AUCs of DL models were improved from 0.943, 0.849, 0.841 to 0.948, 0.890, 0.942 in the combined models (PC + D + DL) at 3%/3 mm, 3%/2 mm and 2%/2 mm, respectively. A best AUC of 0.942 with a sensitivity, specificity and accuracy of 100%, 81.8%, and 83.6% was achieved with combined model (PC + D + DL) at 2%/2 mm. CONCLUSIONS: Integrating DL with dosiomics and PC metrics is promising in the prediction of GPRs in PSQA for patients underwent VMAT. BioMed Central 2023-07-11 /pmc/articles/PMC10334519/ /pubmed/37434171 http://dx.doi.org/10.1186/s13014-023-02311-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Han, Ce
Zhang, Ji
Yu, Bing
Zheng, Haoze
Wu, Yibo
Lin, Zhixi
Ning, Boda
Yi, Jinling
Xie, Congying
Jin, Xiance
Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title_full Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title_fullStr Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title_full_unstemmed Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title_short Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
title_sort integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334519/
https://www.ncbi.nlm.nih.gov/pubmed/37434171
http://dx.doi.org/10.1186/s13014-023-02311-7
work_keys_str_mv AT hance integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT zhangji integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT yubing integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT zhenghaoze integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT wuyibo integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT linzhixi integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT ningboda integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT yijinling integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT xiecongying integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy
AT jinxiance integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy